Tumor-infiltrating CD138+ plasma cells are associated with improved prognosis in NSCLC and colorectal cancer 43, 44, but poor prognosis in breast cancer and epithelial ovarian cancer 45, 46. The gene discussed is SDC1; the disease is breast carcinoma.